Plasmid Profiles of Multidrug Resistant Uropathogens and Antibacterial Efficacy of Leaf Extracts of Luffa cylindrica
Abstract
This study analyzes the antibacterial activity of Luffa cylindrica leaf extracts, the plasmid profile and molecular characterization of MDR Uropathogenic bacteria obtained from patients from selected hospitals in Asaba. Two hundred (200) samples of urine were collected, microscopic examinations, cultures, and susceptibility tests were performed. Bacterial isolates that exhibited resistance to three or more classes of antibiotics were defined, for the purpose of this study, as Multidrug-Resistant (MDR) uropathogens. Molecular identification was performed using 16S rRNA sequencing, while plasmid extraction and curing analyses were used to determine the role of plasmid-mediated resistance. Series of quantitative and qualitative tests were conducted in order to assess the phytochemistry of the leaf extracts, and the antibacterial properties of the extracts were characterized using the agar-well diffusion method, along with a determination of the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). Among the 200 specimens tested, 62 (31%) tested positive in cultures, producing 70 isolates, including Staphylococcus aureus (40%), Escherichia coli (28.6%), Klebsiella pneumonia (18.6%), Proteus mirabilis (7.1%), and Pseudomonas aeruginosa (5.7%). 76% of the isolates were multi-drug resistant (MDR) and Pseudomonas aeruginosa and Proteus mirabilis had 100% resistance. Molecular identification based on 16S rRNA gene sequencing revealed that the isolates…
Read the paper
Related studies
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- GC-MS Analysis and Biomedical Therapy of Oil from n-Hexane Fraction of Scutellaria edelbergii Rech. f.: In Vitro, In Vivo, and In Silico Approach
- Propranolol, chlorpromazine and diclofenac restore susceptibility of extensively drug-resistant (XDR)-Acinetobacter baumannii to fluoroquinolones
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.